keyword
https://read.qxmd.com/read/38640298/identification-of-two-distinct-head-and-neck-squamous-cell-carcinoma-subtypes-based-on-fatty-acid-metabolism-related-signatures-implications-for-immunotherapy-and-chemotherapy
#1
JOURNAL ARTICLE
Jianjun Zou, Yanbi Dai, Guangbo Xu, Yilong Kai, Lingfeng Lan, Junkun Zhang, Yufeng Wang
The dysregulation of lipid metabolism is a critical factor in the initiation and progression of tumors. In this investigation, we aim to characterize the molecular subtypes of head and neck squamous cell carcinoma (HNSCC) based on their association with fatty acid metabolism and develop a prognostic risk model. The transcriptomic and clinical data about HNSCC were obtained from public databases. Clustering analysis was conducted on fatty acid metabolism genes (FAMG) associated with prognosis, utilizing the non-negative matrix factorization algorithm...
April 19, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38639959/-a-review-on-the-application-of-image-fusion-technology-in-prostate-cancer-radiotherapy-based-on-gold-fiducial-biomarker
#2
JOURNAL ARTICLE
Jian-Cheng Zhao, Long Tian
Image fusion technology had been widely applied in image guided radiotherapy (IGRT) for prostate cancer (PCa) based on the gold fiducial mark (GFM). Image fusion technology included the fusion of CT image, magnetic resonance image, and ultrasound image internally or externally. The application of image fusion technology had improved the identification accuracy of GFM and was helpful for the plan design of PCa radiotherapy. This article provided a systematic review of the application of fusion of various medical images in PCa IGRT in recent years...
December 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38639859/management-of-extraocular-retinoblastoma-icmr-consensus-guidelines
#3
REVIEW
Renu Madan, Venkatraman Radhakrishnan, Rachna Meel, Girish Chinnaswamy, Lata Singh, Suyash Kulkarni, Archana Sasi, Tanvir Kaur, Jyoti Sharma, R S Dhaliwal, Meena Haldorai, Gaura Kishore Rath, Sameer Bakhshi
Retinoblastoma (RB) is the most common intraocular malignancy of childhood. Advanced stage presentation of RB is common in low middle-income countries (LMICs) due to lack of awareness, social taboos associated with enucleation, seeking alternative conservative treatment options, and poor accessibility to health care. Over the last few decades, there have been significant advancements in the management of extraocular RB (EORB) which have improved outcomes and helped in minimizing treatment-related toxicities...
April 19, 2024: Indian Journal of Pediatrics
https://read.qxmd.com/read/38639842/high-keratin-15-expression-reflects-favorable-prognosis-in-early-cervical-cancer-patients
#4
JOURNAL ARTICLE
Li Zhou, Ying Bi, Xiaoling Wu, Hong He
OBJECTIVE: Keratin 15 (KRT15) exhibits inconsistent prognostic roles in different cancers, and its prognostic value in early cervical cancer patients who receive tumor resection remains unknown. This study aimed to assess the relationship of KRT15 expression with prognosis in these patients. METHODS: Totally, 147 early cervical cancer patients who received tumor resection were reviewed in this retrospective study. KRT15 was detected in formalin-fixed paraffin-embedded tumor tissue by immunohistochemistry (IHC)...
April 19, 2024: Irish Journal of Medical Science
https://read.qxmd.com/read/38639840/the-impact-of-the-covid-19-pandemic-on-symptomatic-breast-cancer-presentations-in-an-irish-breast-cancer-unit-a-retrospective-cohort-study
#5
JOURNAL ARTICLE
Áine Higgins, Seamus O'Reilly, Martin J O'Sullivan
BACKGROUND: The coronavirus-19 (COVID-19) pandemic caused delays in the diagnosis and management of breast cancer which may have affected disease presentation. The aim of this study was to compare rates of metastatic disease, tumour characteristics and management in breast cancer patients diagnosed before and after the onset of COVID-19. METHODS: A retrospective chart review was conducted on patients in a university teaching hospital who were diagnosed with invasive symptomatic breast cancer in 2019 (prepandemic control group) and in 2020, 2021, and 2022 (pandemic study groups)...
April 19, 2024: Irish Journal of Medical Science
https://read.qxmd.com/read/38639763/efficacy-of-natural-enzymes-mouthwash-a-randomised-controlled-trial
#6
JOURNAL ARTICLE
Thao Liang Chiam, Jowayne Choo, Atika Ashar, Haizal Mohd Hussaini, Rama Krsna Rajandram, Rifqah Nordin
OBJECTIVES: Natural enzymes mouthwash has been proposed as salivary substitutes to treat xerostomia. This study aims to evaluate the efficacy of the mouthwash to treat xerostomia. MATERIALS AND METHODS: A double-blind, parallel group randomised control clinical trial involving N = 49 adult participants with xerostomia was carried out. Intervention group received natural enzymes moisturising mouthwash (with active ingredients lactoferrin, lysozyme, lactoperoxidase and glucose oxidase); while control group received benzydamine mouthwash...
April 19, 2024: Clinical Oral Investigations
https://read.qxmd.com/read/38639666/-application-of-imchb-based-nursing-model-in-self-efficacy-and-negative-emotion-of-prostate-cancer-radiotherapy-patients
#7
JOURNAL ARTICLE
Qing Zhang, Qian Lan, Zhen-Zhu Cao, Juan Li, Xin Zhao, Ao-Mei Li
OBJECTIVE: To study the impact of the nursing model based on the interactive model of health behavior (IMCHB) on the self-efficacy and negative emotions of prostate cancer patients. METHODS: 70 cases clinically admitted to our hospital from January 1, 2021 to January 31, 2023 Patients who received radiotherapy for prostate cancer were taken as research subjects and divided into a control group (n=35) and an observation group (n=35) according to the random drawing method...
October 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38639661/-study-on-the-efficacy-and-complications-of-patients-undergoing-radical-surgery-and-radical-radiotherapy-for-localized-prostate-cancer
#8
JOURNAL ARTICLE
Xiu-Quan Shi, Shi-Hao Wang, Zhe Liu, Long-Wei Lu, Song Xu, Dian Fu, Wen Cheng
OBJECTIVE: To compare the efficacy and complications of radical surgery (RP) and radical radiotherapy (RRT). METHODS: The clinical data of patients diagnosed with localized prostate cancer in General Hospital of Eastern Theater Command with RP and RRT from January 2015 to December 2019, Observed and recorded patient preoperative and postoperative PSA levels, biochemical Relapse-free Survival and clinical Relapse-free Survival,and the occurrence of hematuria, urinary incontinence, erectile dysfunction, ankylurethria, diarrhea, hemoproctia and radiocystitis...
October 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38639653/automated-determination-of-the-ion-recombination-correction-factor-k-sat-in-ultra-high-dose-rate-electron-radiation-therapy
#9
JOURNAL ARTICLE
Michaël Claessens, Verdi Vanreusel, Alessia Gasparini, Luana de Freitas Nascimento, Burak Yalvec, Brigitte Reniers, Dirk Verellen
BACKGROUND: Plane-parallel ionization chambers are the recommended secondary standard systems for clinical reference dosimetry of electrons. Dosimetry in high dose rate and dose-per-pulse (DPP) is challenging as ionization chambers are subject to ion recombination, especially when dose rate and/or DPP is increased beyond the range of conventional radiotherapy. The lack of universally accepted models for correction of ion recombination in UDHR is still an issue as it is, especially in FLASH-RT research, which is crucial in order to be able to accurately measure the dose for a wide range of dose rates and DPPs...
April 19, 2024: Medical Physics
https://read.qxmd.com/read/38639614/identification-of-prognostic-markers-of-glioblastoma-through-bioinformatics-analysis
#10
JOURNAL ARTICLE
Jieying Wen, Haojie Zheng, Xi Yuan, Cuilan Huang, Xiaogang Yang, Zhiying Lin, Guanglong Huang
OBJECTIVE: Glioblastoma is the most common and aggressive type of the central nervous system cancers. Although radiotherapy and chemotherapy are used in the treatment of glioblastoma, survival rates remain unsatisfactory. This study aimed to explore differentially expressed genes (DEGs) based on the survival prognosis of patients with glioblastoma and to establish a model for classifying patients into different risk groups for overall survival. METHODS: DEGs from 160 tumor samples from patients with glioblastoma and 5 nontumor samples from other patients in The Cancer Genome Atlas database were identified...
April 18, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38639607/efficacy-and-safety-of-recombinant-human-p53-adenovirus-injection-combined-with-radiotherapy-or-concurrent-chemoradiotherapy-in-the-treatment-of-cervical-cancer-a-systematic-review-and-meta-analysis
#11
JOURNAL ARTICLE
Guangshu Zhang, Guizhen Su
OBJECTIVE: Cervical cancer remains a major health concern globally, and combined modality treatment often includes radiotherapy or concurrent chemoradiotherapy. Recently, recombinant human adenovirus-p53 (rAd-p53) has been introduced as a promising agent in treatment of cervical cancer. METHODS: We conducted a systematic review and meta-analysis following the PRISMA guidelines. RCTs were identified through electronic databases without limitations on time or language...
April 18, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38639322/evaluation-of-subjective-tinnitus-severity-and-distortion-product-otoacoustic-emissions-and-extended-high-frequency-audiometry
#12
JOURNAL ARTICLE
Sruti Tekumalla, Natalie M Perlov, Saket Gokhale, Samiat Awosanya, Zachary D Urdang, Julia Croce, Anna Bixler, Thomas O Willcox, Rebecca C Chiffer, Dennis Fitzgerald
OBJECTIVE: Tinnitus is a multifactorial phenomenon with quality-of-life detriments for those affected by it. We aim to establish a relationship between subjective tinnitus severity with objective audiometric data in the extended high frequency (EHF) from 9 to 16 khz and with distortion product otoacoustic emissions (DPOAE). We hypothesize that severe subjective tinnitus as measured by the Tinnitus Handicap Inventory (THI) does not correlate with increased hearing thresholds in the EHF range...
April 19, 2024: Otolaryngology—Head and Neck Surgery
https://read.qxmd.com/read/38639185/the-role-of-ferroptosis-in-radiotherapy-and-combination-therapy-for-head-and-neck-squamous-cell-carcinoma-review
#13
JOURNAL ARTICLE
Yu Feng, Xiulei Li, Bingwu Yang, Maocai Li, Yongya Du, Jing Wang, Siyu Liu, Lili Gong, Lianqing Li, Lei Gao
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive, heterogeneous tumour usually caused by alcohol and tobacco consumption, making it one of the most common malignancies worldwide. Despite the fact that various therapeutic approaches such as surgery, radiation therapy (RT), chemotherapy (CT) and targeted therapy have been widely used for HNSCC in recent years, its recurrence rate and mortality rate remain high. RT is the standard treatment choice for HNSCC, which induces reactive oxygen species production and causes oxidative stress, ultimately leading to tumour cell death...
June 2024: Oncology Reports
https://read.qxmd.com/read/38638854/high-pd-l1-expression-on-immune-cells-along-with-increased-density-of-tumor-infiltrating-lymphocytes-predicts-a-favorable-survival-outcome-for-patients-with-loco-regionally-advanced-head-and-neck-cancer-early-results-from-a-prospective-study
#14
JOURNAL ARTICLE
Tomáš Blažek, Marek Petráš, Pavel Hurník, Petr Matoušek, Lukáš Knybel, Zuzana Zděblová Čermáková, Jan Štembírek, Jakub Cvek, Renata Soumarová
INTRODUCTION: In the era of personalized medicine and treatment optimization, use of immune biomarkers holds promise for estimating the prognosis of patients with head and neck squamous cell carcinoma (HNSCC) undergoing definitive treatment. METHODS: To evaluate the prognostic potential of immune biomarkers, we conducted a prospective monocentric cohort study with loco-regionally advanced HNSCC patients indicated for definitive radiotherapy/radiochemotherapy at the Department of Oncology, Ostrava University Hospital, Czech Republic, between June 2020 and August 2023...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38638430/ptms-of-pd-1-pd-l1-and-protacs-application-for-improving-cancer-immunotherapy
#15
REVIEW
Xiaohui Ren, Lijuan Wang, Likun Liu, Juan Liu
Immunotherapy has been developed, which harnesses and enhances the innate powers of the immune system to fight disease, particularly cancer. PD-1 (programmed death-1) and PD-L1 (programmed death ligand-1) are key components in the regulation of the immune system, particularly in the context of cancer immunotherapy. PD-1 and PD-L1 are regulated by PTMs, including phosphorylation, ubiquitination, deubiquitination, acetylation, palmitoylation and glycosylation. PROTACs (Proteolysis Targeting Chimeras) are a type of new drug design technology...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38638256/guiding-function-of-positron-emission-tomography-computed-tomography-examination-in-the-diagnosis-and-treatment-of-ocular-adnexal-mucosa-associated-lymphoid-tissue-lymphoma
#16
JOURNAL ARTICLE
Xuan Zhang, Qi-Han Guo, Rui Liu, Jing Li, Ying-Chao Li, Jian-Min Ma
AIM: To explore the role of positron emission tomography-computed tomography (PET-CT) examination in the diagnosis and treatment of ocular adnexal mucosa associated lymphoid tissue lymphoma (OAML). METHODS: The general clinical data, postoperative PET-CT results, treatment regimens, and the prognosis of 21 histopathologically confirmed OAML patients between October 2017 and September 2021 were collected. Among the 21 patients, five patients underwent surgical treatment alone, 13 patients underwent surgical treatment combined with radiotherapy, and three patients underwent surgical treatment combined with chemotherapy...
2024: International Journal of Ophthalmology
https://read.qxmd.com/read/38638194/primary-intranasal-melanotic-mucosal-melanoma-a-case-report-and-literature-review
#17
Samson Dires Gashaw, Waltengus Demissie Birhanu, Fitsum Alemayehu
BACKGROUND: Intranasal mucosal melanoma is a rare form of melanoma. Presenting as the features of occult malignancy and rapid in its progression. Presented with nonspecific symptoms. So far, no specific risk factor has been identified. The histopathological and immunohistochemical examination helps to confirm the diagnosis. Here, we present a case of primary intranasal melanotic mucosal melanoma and literature review. CASE REPORT: The authors present a patient with primary right intranasal melanotic mucosal melanoma...
2024: International Medical Case Reports Journal
https://read.qxmd.com/read/38637940/risk-factors-influencing-postoperative-pleural-empyema-in-patients-with-pleural-mesothelioma-a-retrospective-single-centre-analysis
#18
JOURNAL ARTICLE
Peter Henschke, Laura Guglielmetti, Sven Hillinger, Gian-Marco Monsch, Didier Schneiter, Isabelle Opitz, Olivia Lauk
OBJECTIVES: Postoperative empyema is a severe, potentially lethal complication also present, but poorly studied in patients undergoing surgery for pleural mesothelioma. We aimed to analyse which perioperative characteristics might be associated with an increased risk for postoperative empyema. METHODS: From September 1999 to February 2023 a retrospective analysis of consecutive patients undergoing surgery for pleural mesothelioma at the University Hospital of Zurich was performed...
April 18, 2024: European Journal of Cardio-thoracic Surgery
https://read.qxmd.com/read/38637844/survival-analysis-after-stereotactic-ablative-radiotherapy-for-early-stage-non-small-cell-lung-cancer-a-single-institution-cohort-study
#19
JOURNAL ARTICLE
Kamila Resova, Lukas Knybel, Tereza Parackova, Marian Rybar, Karel Cwiertka, Jakub Cvek
BACKGROUND: Stereotactic ablative radiotherapy (SABR) is the standard treatment for medically inoperable early-stage non-small cell lung cancer (ES-NSCLC), but which patients benefit from stereotactic radiotherapy is unclear. The aim of this study was to analyze prognostic factors for early mortality. METHODS: From August 2010 to 2022, 617 patients with medically inoperable, peripheral or central ES-NSCLC were treated with SABR at our institution. We retrospectively evaluated the data from 172 consecutive patients treated from 2018 to 2020 to analyze the prognostic factors associated with overall survival (OS)...
April 18, 2024: Radiation Oncology
https://read.qxmd.com/read/38637772/anti-pd-1-antibody-in-combination-with-radiotherapy-as-first-line-therapy-for-unresectable-intrahepatic-cholangiocarcinoma
#20
JOURNAL ARTICLE
Meiyan Zhu, Meng Jin, Xiao Zhao, Shunli Shen, Yihan Chen, Han Xiao, Guangyan Wei, Qiang He, Bin Li, Zhenwei Peng
BACKGROUND: Unresectable intrahepatic cholangiocarcinoma (iCCA) has a poor prognosis despite treatment with standard combination chemotherapy. We aimed to evaluate the efficacy and safety of radiotherapy in combination with an anti-PD-1 antibody in unresectable iCCA without distant metastases. METHODS: In this phase II study, patients with histopathologically confirmed unresectable primary or postoperative recurrent iCCA without distant metastases were enrolled...
April 19, 2024: BMC Medicine
keyword
keyword
1510
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.